Abstract
Objective To explore the role of contact system activation in the mechanism of systemic lupus erythematosus (SLE) patients with thrombotic events. Methods A simple sample drawing study was conducted. Sixty-nine patients with SLE admitted to Department of Rheumatism in Tianjin Hospital from June 2014 to February 2016 were enrolled. The patients were divided into simple SLE group (n = 38) and SLE + vascular diseases (VD) group (n = 31) according to whether the patients complicated with VD or not. The VD patients were subdivided into three subgroups including SLE complicated with myocardial infarction (SLE + MI, n = 10), SLE complicated with deep vein thrombosis (SLE + DVT, n = 13), and SLE complicated with arterial thrombosis (SLE + AT, n = 8). Sixty-eight healthy age and gender-matched volunteers without history of VD were served as controls. Enzyme-linked immunosorbent assay (ELISA) was used to detect the content of FⅫa-C1 inhibitor (FⅫa-C1INH) and FⅫa-antithrombin (FⅫa-AT) in plasma. Flow cytometry was used to analyze the contents of platelets associated factors. The correlation between platelet associated factor and FⅫA-C1INH and FⅫa-AT was analyzed by Spearman correlation analysis. Receiver operating characteristic curve (ROC) was plotted to analyze the predictive value of FⅫA-C1INH and FⅫa-AT for SLE thrombotic events. Results Compared with health control group, the expression of FⅫa-C1INH in plasma in SLE group was significantly decreased [nmol/L: 0.00 (0.00, 0.07) vs. 0.08 (0.03, 0.13), P 0.40 nmol/L; predicted probability of two markers for predicting diagnosis was 0.5, the sensitivity and specificity were both 100%. Conclusions Contact system is activated in patients with SLE. FⅫA-C1INH and FⅫa-AT levels are closely related with platelet associated factors IFITM1 and PRKRA. FⅫA-C1INH and FⅫa-AT can be served as a promising potential biomarker for evaluation of the risk of thrombotic events in SLE. Key words: Systemic lupus erythematosus; Contact system; Thrombotic event
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.